The World Health Organization (WHO) has announced the recall of an eye drugmanufactured by Indian pharma Galentic Pharma Pvt Ltd administered on children from global markets.
The Maharashtra based drug company manufactures the tetracycline hydrochloride ophthalmic ointment USP 1% drug. However, there is currently no established evidence of any adverse events from the affected batches of the product. Redness and swollen eyes are common reactions to general use of tetracycline eye ointment.